Literature DB >> 24464870

mir-300 promotes self-renewal and inhibits the differentiation of glioma stem-like cells.

Daming Zhang1, Guang Yang, Xin Chen, Chunmei Li, Lu Wang, Yaohua Liu, Dayong Han, Huailei Liu, Xu Hou, Weiguang Zhang, Chenguang Li, Zhanqiang Han, Xin Gao, Shiguang Zhao.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that have been critically implicated in several human cancers. miRNAs are thought to participate in various biological processes, including proliferation, cell cycle, apoptosis, and even the regulation of the stemness properties of cancer stem cells. In this study, we explore the potential role of miR-300 in glioma stem-like cells (GSLCs). We isolated GSLCs from glioma biopsy specimens and identified the stemness properties of the cells through neurosphere formation assays, multilineage differentiation ability analysis, and immunofluorescence analysis of glioma stem cell markers. We found that miR-300 is commonly upregulated in glioma tissues, and the expression of miR-300 was higher in GSLCs. The results of functional experiments demonstrated that miR-300 can enhance the self-renewal of GSLCs and reduce differentiation toward both astrocyte and neural fates. In addition, LZTS2 is a direct target of miR-300. In conclusion, our results demonstrate the critical role of miR-300 in GSLCs and its functions in LZTS2 inhibition and describe a new approach for the molecular regulation of tumor stem cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24464870     DOI: 10.1007/s12031-014-0230-x

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  26 in total

1.  Integrin alpha 6 regulates glioblastoma stem cells.

Authors:  Justin D Lathia; Joseph Gallagher; John M Heddleston; Jialiang Wang; Christine E Eyler; Jennifer Macswords; Qiulian Wu; Amit Vasanji; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

2.  Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development.

Authors:  Daniel T Johnson; Richard Luong; Suk Hyung Lee; Yue Peng; Atossa Shaltouki; Jane T Lee; Dong Lin; Yuzhuo Wang; Zijie Sun
Journal:  J Biol Chem       Date:  2012-12-28       Impact factor: 5.157

3.  MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.

Authors:  Guang Yang; Ruyou Zhang; Xiaofeng Chen; Yulong Mu; Jing Ai; Chen Shi; Yaohua Liu; Changbin Shi; Lihua Sun; Nikolai G Rainov; Hulun Li; Baofeng Yang; Shiguang Zhao
Journal:  J Mol Med (Berl)       Date:  2011-06-09       Impact factor: 4.599

4.  miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.

Authors:  Kun Wang; Xuan Wang; Jian Zou; Anling Zhang; Yingfeng Wan; Peiyu Pu; Zhengfei Song; Cong Qian; Yili Chen; Shuxu Yang; Yirong Wang
Journal:  Neuro Oncol       Date:  2013-02-14       Impact factor: 12.300

5.  Isolation of cancer stem cells from adult glioblastoma multiforme.

Authors:  Xiangpeng Yuan; James Curtin; Yizhi Xiong; Gentao Liu; Sebastian Waschsmann-Hogiu; Daniel L Farkas; Keith L Black; John S Yu
Journal:  Oncogene       Date:  2004-12-16       Impact factor: 9.867

6.  Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells.

Authors:  Hongping Xia; William K C Cheung; Samuel S Ng; Xiaochun Jiang; Songshan Jiang; Johnny Sze; Gilberto K K Leung; Gang Lu; Danny T M Chan; Xiu-Wu Bian; Hsiang-fu Kung; Wai Sang Poon; Marie C Lin
Journal:  J Biol Chem       Date:  2012-01-17       Impact factor: 5.157

7.  Surgical outcomes in recurrent glioma: clinical article.

Authors:  Jason M Hoover; Macaulay Nwojo; Ross Puffer; Jay Mandrekar; Fredric B Meyer; Ian F Parney
Journal:  J Neurosurg       Date:  2013-03-15       Impact factor: 5.115

8.  Crossregulation of beta-catenin/Tcf pathway by NF-kappaB is mediated by lzts2 in human adipose tissue-derived mesenchymal stem cells.

Authors: 
Journal:  Biochim Biophys Acta       Date:  2007-08-31

9.  Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.

Authors:  Roberto Pallini; Lucia Ricci-Vitiani; Giuseppe Luigi Banna; Michele Signore; Dario Lombardi; Matilde Todaro; Giorgio Stassi; Maurizio Martini; Giulio Maira; Luigi Maria Larocca; Ruggero De Maria
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

10.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more
  13 in total

1.  miR-300 regulates cellular radiosensitivity through targeting p53 and apaf1 in human lung cancer cells.

Authors:  Jinpeng He; Xiu Feng; Junrui Hua; Li Wei; Zhiwei Lu; Wenjun Wei; Hui Cai; Bing Wang; Wengui Shi; Nan Ding; He Li; Yanan Zhang; Jufang Wang
Journal:  Cell Cycle       Date:  2017-09-12       Impact factor: 4.534

2.  Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7.

Authors:  Zhen Xue; Jindong Zhao; Liyuan Niu; Gang An; Yashan Guo; Linying Ni
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

3.  Serum miR-300 as a diagnostic and prognostic biomarker in osteosarcoma.

Authors:  Jian-Dong Liu; Qun Xin; Chun-Sheng Tao; Pei-Feng Sun; Peng Xu; Bing Wu; Liang Qu; Shu-Zhong Li
Journal:  Oncol Lett       Date:  2016-09-29       Impact factor: 2.967

4.  miR-200b inhibits CD133+ glioma cells by targeting the AKT pathway.

Authors:  Aiqun Liu; Qingyun Yu; Zhongxing Peng; Yeqing Huang; Shengpeng Diao; Jing Cheng; Wentao Wang; Mingfan Hong
Journal:  Oncol Lett       Date:  2017-04-20       Impact factor: 2.967

5.  miR-300 rs12894467 polymorphism may be associated with susceptibility to primary lung cancer in the Chinese Han population.

Authors:  Zhiqiang Liu; Yong Lin; Shuling Kang; Qiuping Xu; Weimin Xiong; Lin Cai; Fei He
Journal:  Cancer Manag Res       Date:  2018-09-17       Impact factor: 3.989

6.  The Transcriptome of Type I Murine Astrocytes under Interferon-Gamma Exposure and Remyelination Stimulus.

Authors:  Anna Kudriaeva; Vladimir V Galatenko; Diana V Maltseva; Nadezhda A Khaustova; Ekaterina Kuzina; Alexander G Tonevitsky; Alexander Gabibov; Alexey Belogurov
Journal:  Molecules       Date:  2017-05-15       Impact factor: 4.411

7.  WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.

Authors:  Ching-Chia Lin; Po-Chun Chen; Ming-Yu Lein; Ching-Wen Tsao; Chiu-Chen Huang; Shih-Wei Wang; Chih-Hsin Tang; Kwong-Chung Tung
Journal:  Oncotarget       Date:  2016-03-01

Review 8.  Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment.

Authors:  Lavinia Raimondi; Angela De Luca; Viviana Costa; Nicola Amodio; Valeria Carina; Daniele Bellavia; Pierfrancesco Tassone; Stefania Pagani; Milena Fini; Riccardo Alessandro; Gianluca Giavaresi
Journal:  Oncotarget       Date:  2017-08-03

9.  MicroRNA-300 inhibited glioblastoma progression through ROCK1.

Authors:  Fucheng Zhou; Yang Li; Zhen Hao; Xuanxi Liu; Liang Chen; Yu Cao; Zuobin Liang; Fei Yuan; Jie Liu; Jianjiao Wang; Yongri Zheng; Deli Dong; Shan Bian; Baofeng Yang; Chuanlu Jiang; Qingsong Li
Journal:  Oncotarget       Date:  2016-06-14

10.  Transcriptional Repression of p53 by PAX3 Contributes to Gliomagenesis and Differentiation of Glioma Stem Cells.

Authors:  Hui Zhu; Hongkui Wang; Qingfeng Huang; Qianqian Liu; Yibing Guo; Jingjing Lu; Xiaohong Li; Chengbin Xue; Qianqian Han
Journal:  Front Mol Neurosci       Date:  2018-06-08       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.